Tech Company Financing Transactions
Adrenergics Funding Round
Avalon Ventures and private investors participated in a $10 million capital raise for Adrenergics. The round was recorded on 6/30/2015.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Adrenergics, Inc. develops therapeutics to treat dilated cardiomyopathy (DCM) in patients that do not respond to existing therapies. The company was incorporated in 2014.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Munk
Browse more venture capital transactions:
Prev: 6/30/2015: Global Learning U venture capital transaction
Next: 6/30/2015: TabbedOut venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs